Literature DB >> 7608662

Surgical treatment of temporal lobe epilepsy: clinical, radiological, and histopathological findings in 178 patients.

J Zentner1, A Hufnagel, H K Wolf, B Ostertun, E Behrens, M G Campos, L Solymosi, C E Elger, O D Wiestler, J Schramm.   

Abstract

The surgical treatment of pharmacoresistant temporal lobe epilepsy is increasing rapidly. The correlation of preoperative MRI, histopathological findings, and postoperative seizure control is reported for 178 patients with chronic medically intractable temporal lobe epilepsy who were operated on between November 1987 and January 1993. Histopathologically there were distinct structural abnormalities in 97.2% of the surgical specimens. Signal abnormalities on MRI were present in 98.7% of patients with neoplastic lesions (n = 79), 76.6% of patients with non-neoplastic focal lesions (n = 55), and 69.2% of patients with Ammon's horn sclerosis (n = 39). Overall, structural abnormalities were detected by MRI in 82.7% of all patients. The mean postoperative follow up period was three years. Some 92% of the patients benefited from surgery: 103 patients (61.7%) were seizure free, 26 (15.5%) had no more than two seizures a year, and 24 (14.4%) showed a reduction of seizure frequency of at least 75%. Fourteen patients (8.4%) had a < 75% reduction of seizure frequency. The percentage of patients who were completely free of seizures after operation was 68.5% for patients with neoplastic lesions, 66.7% for Ammon's horn sclerosis, and 54.0% for patients with non-neoplastic focal lesions. By contrast, none of the patients in whom histopathological findings were normal became seizure free postoperatively. The data show that the presence of focal lesions or Ammon's horn sclerosis as determined by histopathological examination is associated with improved postoperative seizure control compared with patients without specific pathological findings. Brain MRI was very sensitive in detecting neoplasms; however, its sensitivity and specificity were limited with respect to non-neoplastic focal lesions and Ammon's horn sclerosis. Improvement of imaging techniques may provide a more precise definition of structural lesions in these cases and facilitate limited surgical resections of the epileptogenic area rather than standardised anatomical resections.

Entities:  

Mesh:

Year:  1995        PMID: 7608662      PMCID: PMC1073541          DOI: 10.1136/jnnp.58.6.666

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  46 in total

1.  Electroencephalography, magnetic resonance imaging and pathology in patients treated surgically for temporal lobe epilepsy.

Authors:  W Feindel; Y Robitaille; D Tampieri; L Goossens; M Li; D Melançon
Journal:  Can J Neurol Sci       Date:  1991-11       Impact factor: 2.104

2.  Neuroimaging in refractory partial seizures: comparison of PET, CT, and MRI.

Authors:  W H Theodore; R Dorwart; M Holmes; R J Porter; G DiChiro
Journal:  Neurology       Date:  1986-06       Impact factor: 9.910

3.  Magnetic resonance imaging (1.5 tesla) in patients with intractable focal seizures.

Authors:  R P Lesser; M T Modic; M A Weinstein; P M Duchesneau; H Lüders; D S Dinner; H H Morris; M Estes; S M Chou; J F Hahn
Journal:  Arch Neurol       Date:  1986-04

4.  Nonrefractory temporal lobe epilepsy: 1.5-T MR imaging.

Authors:  F Triulzi; M Franceschi; F Fazio; A Del Maschio
Journal:  Radiology       Date:  1988-01       Impact factor: 11.105

5.  Cryptic structural lesions in refractory partial epilepsy: MR imaging and CT studies.

Authors:  M J Ormson; D B Kispert; F W Sharbrough; O W Houser; F Earnest; B W Scheithauer; E R Laws
Journal:  Radiology       Date:  1986-07       Impact factor: 11.105

6.  Magnetic resonance imaging-based volume studies in temporal lobe epilepsy: pathological correlations.

Authors:  G D Cascino; C R Jack; J E Parisi; F W Sharbrough; K A Hirschorn; F B Meyer; W R Marsh; P C O'Brien
Journal:  Ann Neurol       Date:  1991-07       Impact factor: 10.422

7.  Intracerebral gangliogliomas in patients with partial complex seizures: CT and MR imaging findings.

Authors:  D Tampieri; R Moumdjian; D Melanson; R Ethier
Journal:  AJNR Am J Neuroradiol       Date:  1991 Jul-Aug       Impact factor: 3.825

8.  Atrophy of mesial structures in patients with temporal lobe epilepsy: cause or consequence of repeated seizures?

Authors:  F Cendes; F Andermann; P Gloor; I Lopes-Cendes; E Andermann; D Melanson; M Jones-Gotman; Y Robitaille; A Evans; T Peters
Journal:  Ann Neurol       Date:  1993-12       Impact factor: 10.422

9.  Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases.

Authors:  C Daumas-Duport; B W Scheithauer; J P Chodkiewicz; E R Laws; C Vedrenne
Journal:  Neurosurgery       Date:  1988-11       Impact factor: 4.654

10.  Temporal lobectomy for epilepsy: mesial temporal herniation as an operative and prognostic finding.

Authors:  D A Turner; A R Wyler
Journal:  Epilepsia       Date:  1981-12       Impact factor: 5.864

View more
  17 in total

1.  Oligodendroglial hamartoma: a potential source of misdiagnosis for oligodendroglioma.

Authors:  Gianluca Marucci; Marco Giulioni; Matteo Martinoni; Lilia Volpi; Roberto Michelucci
Journal:  J Neurooncol       Date:  2010-06-08       Impact factor: 4.130

2.  Comparison of manual tracing versus a semiautomatic radial measurement method in temporal lobe MRI volumetry for pharmacoresistant epilepsy.

Authors:  Christian-Andreas Mueller; Jasmin Scorzin; Roy Koenig; Horst Urbach; Rolf Fimmers; Josef Zentner; Thomas-Nicolas Lehmann; Johannes Schramm
Journal:  Neuroradiology       Date:  2006-11-28       Impact factor: 2.804

3.  Surgery for epilepsy.

Authors:  Siobhan West; Sarah J Nevitt; Jennifer Cotton; Sacha Gandhi; Jennifer Weston; Ajay Sudan; Roberto Ramirez; Richard Newton
Journal:  Cochrane Database Syst Rev       Date:  2019-06-25

Review 4.  The preoperative evaluation and surgical treatment of epilepsy.

Authors:  Andreas Schulze-Bonhage; Josef Zentner
Journal:  Dtsch Arztebl Int       Date:  2014-05-02       Impact factor: 5.594

5.  Correlation of apparent diffusion coefficient with neuropsychological testing in temporal lobe epilepsy.

Authors:  Yvonne W Lui; Annette O Nusbaum; William B Barr; Glyn Johnson; James S Babb; Darren Orbach; Alice Kim; Georgia Laliotis; Orrin Devinsky
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

6.  Seizure outcome after epilepsy surgery in patients with normal preoperative MRI.

Authors:  K Chapman; E Wyllie; I Najm; P Ruggieri; W Bingaman; J Lüders; P Kotagal; D Lachhwani; D Dinner; H O Lüders
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

Review 7.  Management of primary malignant brain tumours.

Authors:  I R Whittle
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

8.  Predictors of outcome and pathological considerations in the surgical treatment of intractable epilepsy associated with temporal lobe lesions.

Authors:  M J Hennessy; R D Elwes; M Honavar; S Rabe-Hesketh; C D Binnie; C E Polkey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

9.  Lesional mesial temporal lobe epilepsy and limited resections: prognostic factors and outcome.

Authors:  H Clusmann; T Kral; E Fackeldey; I Blümcke; C Helmstaedter; J von Oertzen; H Urbach; J Schramm
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

10.  Outcome after individualized stereoelectroencephalography (sEEG) implantation and navigated resection in patients with lesional and non-lesional focal epilepsy.

Authors:  Jun Thorsteinsdottir; Christian Vollmar; Jörg-Christian Tonn; Friedrich-Wilhelm Kreth; Soheyl Noachtar; Aurelia Peraud
Journal:  J Neurol       Date:  2019-01-30       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.